{"pmid":32470156,"title":"The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.","text":["The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.","Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID-19 patients. A higher frequency of PE than expected in COVID-19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID-19, especially in those patients with ARDS. We reported two COVID-19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID-19 may be related to PE and not necessarily always due to the parenchymal disease. This article is protected by copyright. All rights reserved.","J Med Virol","Li, Ting","Cheng, Guang-Shing","Pipavath, Sudhakar","Kicska, Gregory","Liu, Liangjin","Kinahan, Paul E","Wu, Wei","32470156"],"abstract":["Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID-19 patients. A higher frequency of PE than expected in COVID-19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID-19, especially in those patients with ARDS. We reported two COVID-19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID-19 may be related to PE and not necessarily always due to the parenchymal disease. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Li, Ting","Cheng, Guang-Shing","Pipavath, Sudhakar","Kicska, Gregory","Liu, Liangjin","Kinahan, Paul E","Wu, Wei"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470156","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26068","keywords":["ards","covid-19","hypoxemia","pe"],"topics":["Case Report"],"weight":1,"_version_":1668420887192272896,"score":9.490897,"similar":[{"pmid":32313884,"pmcid":"PMC7164919","title":"COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure.","text":["COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure.","A patient with Coronavirus Disease-2019 (COVID-19) developed sudden shortness of breath and hypoxia. She was diagnosed with a massive pulmonary embolism (PE) complicated by right sided heart failure, which was successfully managed conservatively. This marks the first report of COVID-19 induced PE in association with acute heart failure.","JACC Case Rep","Ullah, Waqas","Saeed, Rehan","Sarwar, Usman","Patel, Rajesh","Fischman, David L","32313884"],"abstract":["A patient with Coronavirus Disease-2019 (COVID-19) developed sudden shortness of breath and hypoxia. She was diagnosed with a massive pulmonary embolism (PE) complicated by right sided heart failure, which was successfully managed conservatively. This marks the first report of COVID-19 induced PE in association with acute heart failure."],"journal":"JACC Case Rep","authors":["Ullah, Waqas","Saeed, Rehan","Sarwar, Usman","Patel, Rajesh","Fischman, David L"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313884","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaccas.2020.04.008","keywords":["covid-19","covid-19, coronavirus disease-2019","ekg, electrocardiogram","heart failure","pulmonary embolism","sars-cov-2, severe acute respiratory syndrome coronavirus-2","tte, transthoracic echocardiography"],"topics":["Case Report"],"weight":1,"_version_":1666138493513891840,"score":274.778},{"pmid":32405161,"pmcid":"PMC7219417","title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni","32405161"],"abstract":["Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405161","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845509222400,"score":228.10684},{"pmid":32454268,"title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","OBJECTIVE: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. METHODS: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. RESULTS: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. CONCLUSION: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Abad Capa, Jorge","Rosell, Antoni","32454268"],"abstract":["OBJECTIVE: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. METHODS: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. RESULTS: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. CONCLUSION: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Abad Capa, Jorge","Rosell, Antoni"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454268","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667881798487506945,"score":228.10684},{"pmid":32479682,"title":"Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.","text":["Preeclampsia-like syndrome induced by severe COVID-19: a prospective observational study.","OBJECTIVES: To investigate the incidence of clinical, ultrasonographic and biochemical findings related to preeclampsia (PE) in pregnancies with COVID-19, and to assess their accuracy to differentiate between PE and the PE-like features associated with COVID-19. DESIGN: A prospective, observational study. SETTING: Tertiary referral hospital. PARTICIPANTS: Singleton pregnancies with COVID-19 at >20+0 weeks. METHODS: 42 consecutive pregnancies were recruited and classified into two groups: severe and nonsevere COVID-19, according to the occurrence of severe pneumonia. Uterine artery pulsatility index (UtAPI) and angiogenic factors (soluble fms-like tyrosine kinase-1/placental growth factor [sFlt-1/PlGF]) were assessed in women with suspected PE. MAIN OUTCOME MEASURES: Incidence of signs and symptoms related to PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes, abnormal UtAPI and increased sFlt-1/PlGF. RESULTS: 34 cases were classified as nonsevere and 8 as severe COVID-19. Six (14.3%) women presented signs and symptoms of PE, all six being among the severe COVID-19 cases (75.0%). However, abnormal sFlt-1/PlGF and UtAPI could only be demonstrated in one case. Two cases remained pregnant after recovery from severe pneumonia and had a spontaneous resolution of the PE-like syndrome. CONCLUSIONS: Pregnant women with severe COVID-19 can develop a PE-like syndrome that might be distinguished from actual PE by sFlt-1/PlGF, LDH and UtAPI assessment. Health care providers should be aware of its existence and monitor pregnancies with suspected preeclampsia with caution.","BJOG","Mendoza, Manel","Garcia-Ruiz, Itziar","Maiz, Nerea","Rodo, Carlota","Garcia-Manau, Pablo","Serrano, Berta","Lopez-Martinez, Rosa Maria","Balcells, Joan","Fernandez-Hidalgo, Nuria","Carreras, Elena","Suy, Anna","32479682"],"abstract":["OBJECTIVES: To investigate the incidence of clinical, ultrasonographic and biochemical findings related to preeclampsia (PE) in pregnancies with COVID-19, and to assess their accuracy to differentiate between PE and the PE-like features associated with COVID-19. DESIGN: A prospective, observational study. SETTING: Tertiary referral hospital. PARTICIPANTS: Singleton pregnancies with COVID-19 at >20+0 weeks. METHODS: 42 consecutive pregnancies were recruited and classified into two groups: severe and nonsevere COVID-19, according to the occurrence of severe pneumonia. Uterine artery pulsatility index (UtAPI) and angiogenic factors (soluble fms-like tyrosine kinase-1/placental growth factor [sFlt-1/PlGF]) were assessed in women with suspected PE. MAIN OUTCOME MEASURES: Incidence of signs and symptoms related to PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes, abnormal UtAPI and increased sFlt-1/PlGF. RESULTS: 34 cases were classified as nonsevere and 8 as severe COVID-19. Six (14.3%) women presented signs and symptoms of PE, all six being among the severe COVID-19 cases (75.0%). However, abnormal sFlt-1/PlGF and UtAPI could only be demonstrated in one case. Two cases remained pregnant after recovery from severe pneumonia and had a spontaneous resolution of the PE-like syndrome. CONCLUSIONS: Pregnant women with severe COVID-19 can develop a PE-like syndrome that might be distinguished from actual PE by sFlt-1/PlGF, LDH and UtAPI assessment. Health care providers should be aware of its existence and monitor pregnancies with suspected preeclampsia with caution."],"journal":"BJOG","authors":["Mendoza, Manel","Garcia-Ruiz, Itziar","Maiz, Nerea","Rodo, Carlota","Garcia-Manau, Pablo","Serrano, Berta","Lopez-Martinez, Rosa Maria","Balcells, Joan","Fernandez-Hidalgo, Nuria","Carreras, Elena","Suy, Anna"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479682","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/1471-0528.16339","keywords":["covid-19","plgf","sars","sars-cov-2","angiogenic factors","preeclampsia","preeclampsia-like syndrome","pregnancy","sflt-1"],"locations":["preeclampsia","thrombocytopenia"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1668437835184603136,"score":227.43602},{"pmid":32425320,"pmcid":"PMC7229475","title":"Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.","text":["Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.","A patient presented to the emergency department with altered mental status and lower extremity weakness in the setting of nitrous oxide inhalant abuse and Coronavirus Disease-2019 (COVID-19) infection. He subsequently developed hypotension and severe hypoxia, found to have a saddle pulmonary embolus (PE) with right heart strain requiring alteplase (tPA).","Am J Emerg Med","Molina, Melanie F","Al Saud, Ahad A","Al Mulhim, Abdullah A","Liteplo, Andrew S","Shokoohi, Hamid","32425320"],"abstract":["A patient presented to the emergency department with altered mental status and lower extremity weakness in the setting of nitrous oxide inhalant abuse and Coronavirus Disease-2019 (COVID-19) infection. He subsequently developed hypotension and severe hypoxia, found to have a saddle pulmonary embolus (PE) with right heart strain requiring alteplase (tPA)."],"journal":"Am J Emerg Med","authors":["Molina, Melanie F","Al Saud, Ahad A","Al Mulhim, Abdullah A","Liteplo, Andrew S","Shokoohi, Hamid"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425320","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajem.2020.05.023","e_drugs":["Nitrous Oxide"],"topics":["Case Report"],"weight":1,"_version_":1667252837733629953,"score":224.65535}]}